{"id":210148,"date":"2025-06-24T10:37:14","date_gmt":"2025-06-24T10:37:14","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/210148\/"},"modified":"2025-06-24T10:37:14","modified_gmt":"2025-06-24T10:37:14","slug":"price-of-life-changing-cystic-fibrosis-drug-set-to-be-slashed","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/210148\/","title":{"rendered":"Price of life-changing Cystic Fibrosis drug set to be slashed"},"content":{"rendered":"<p>Australians living with cystic fibrosis will pay a fraction of the price to access a potentially life-changing treatment option from July 1.<\/p>\n<p>\ufeffThe drug Trikafta will be available to adults and children diagnosed with rarer mutations of the disease under changes to the Pharmaceutical Benefits Scheme (PBS).<\/p>\n<p>Without the subsidy, a year of the treatment could cost more than \ufeff$250,000.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.europesays.com\/uk\/wp-content\/uploads\/2025\/06\/https:\/\/prod.static9.net.au\/fs\/54512683-f7e8-42c4-869e-f2bc56e3e287.jpeg\"   alt=\"Australians living with cystic fibrosis will pay a fraction of the price to access a potentially life-changing treatment option.\"\/>Australians living with cystic fibrosis will pay a fraction of the price to access a potentially life-changing treatment option. (Nine)<\/p>\n<p>Through the PBS, people will pay a maximum of $31.60 per script or $7.70 if they have a concession card.<\/p>\n<p>Health Minister Mark Butler said the price would be cheaper from January next year, when the maximum patients pay for PBS medicines will drop to $25 per script.\ufeff<\/p>\n<p>&#8220;This expansion to Trikafta&#8217;s PBS listing is great news for hundreds of Australians who live with rare mutations of CF, including children, and their families,&#8221; Butler said.\ufeff<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.europesays.com\/uk\/wp-content\/uploads\/2025\/06\/https:\/\/prod.static9.net.au\/fs\/2021f631-a12e-42b2-9c3c-ca659a3264f0.jpeg\"   alt=\"People will pay a maximum of $31.60 per script or $7.70 if they have a concession card. \"\/>People will pay a maximum of $31.60 per script or $7.70 if they have a concession card.  (Nine)<\/p>\n<p>Around 180 Australians are expected to benefit from the latest change.\ufeff<\/p>\n<p>Cystic Fibrosis Australia CEO Jo Armstrong said the decision placed Australia as a &#8220;global leader for equitable access to CF therapies&#8221;.<\/p>\n<p>&#8220;This decision means that hundreds of Australians living with cystic fibrosis will now have access to a therapy that was previously out of reach, a treatment that can dramatically improve quality of life and life expectancy,&#8221; Armstrong said.<\/p>\n<p>&#8220;For those who&#8217;ve waited, hoped, and campaigned, this is more than a policy decision, it&#8217;s a transformational outcome.&#8221;<\/p>\n<p>Cystic fibrosis is an incurable genetic disease which causes an abnormal amount of thick and sticky mucous in the lungs, digestive and other systems.<\/p>\n<p>This can cause irreversible damage to lungs and other organs over time.<\/p>\n","protected":false},"excerpt":{"rendered":"Australians living with cystic fibrosis will pay a fraction of the price to access a potentially life-changing treatment&hellip;\n","protected":false},"author":2,"featured_media":210149,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[105,4326,16,15],"class_list":{"0":"post-210148","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication","10":"tag-uk","11":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114737908790385237","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/210148","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=210148"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/210148\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/210149"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=210148"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=210148"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=210148"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}